EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 164 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,467,363 | -17.0% | 219,844 | +2.3% | 0.00% | – |
| Q2 2023 | $4,179,483 | -27.5% | 214,994 | +5.8% | 0.00% | -100.0% |
| Q1 2023 | $5,763,450 | +98353.2% | 203,153 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $5,854 | -99.9% | 200,305 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $5,194,000 | -38.4% | 196,597 | +3.6% | 0.00% | 0.0% |
| Q2 2022 | $8,434,000 | -16.9% | 189,848 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $10,151,000 | -2.5% | 205,122 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $10,408,000 | -12.3% | 204,402 | -3.9% | 0.00% | -50.0% |
| Q3 2021 | $11,861,000 | +37.6% | 212,649 | +5.6% | 0.00% | +100.0% |
| Q2 2021 | $8,622,000 | +11.0% | 201,458 | +8.2% | 0.00% | 0.0% |
| Q1 2021 | $7,769,000 | +6.3% | 186,147 | +18.6% | 0.00% | 0.0% |
| Q4 2020 | $7,309,000 | +7.6% | 156,949 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $6,791,000 | -14.8% | 159,881 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $7,966,000 | +12.1% | 166,037 | +7.5% | 0.00% | 0.0% |
| Q1 2020 | $7,105,000 | -63.3% | 154,469 | -52.1% | 0.00% | 0.0% |
| Q4 2019 | $19,358,000 | +115.3% | 322,234 | +102.7% | 0.00% | 0.0% |
| Q3 2019 | $8,993,000 | +3.0% | 158,990 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $8,729,000 | +14.3% | 156,788 | +3.6% | 0.00% | 0.0% |
| Q1 2019 | $7,639,000 | -28.2% | 151,309 | -42.7% | 0.00% | 0.0% |
| Q4 2018 | $10,638,000 | +28.6% | 264,086 | +121.4% | 0.00% | 0.0% |
| Q3 2018 | $8,269,000 | +7.1% | 119,295 | +16.9% | 0.00% | 0.0% |
| Q2 2018 | $7,719,000 | +84.5% | 102,035 | +28.5% | 0.00% | +100.0% |
| Q1 2018 | $4,184,000 | +0.9% | 79,414 | +2.3% | 0.00% | 0.0% |
| Q4 2017 | $4,146,000 | -25.6% | 77,620 | -17.0% | 0.00% | -50.0% |
| Q3 2017 | $5,576,000 | -21.2% | 93,496 | +4.2% | 0.00% | -33.3% |
| Q2 2017 | $7,080,000 | -5.6% | 89,755 | -0.7% | 0.00% | 0.0% |
| Q1 2017 | $7,498,000 | +33.7% | 90,416 | +27.9% | 0.00% | 0.0% |
| Q4 2016 | $5,609,000 | +17.2% | 70,706 | +3.4% | 0.00% | +50.0% |
| Q3 2016 | $4,787,000 | +83.7% | 68,390 | +1.8% | 0.00% | +100.0% |
| Q2 2016 | $2,606,000 | -6.0% | 67,207 | -1.8% | 0.00% | 0.0% |
| Q1 2016 | $2,771,000 | -55.3% | 68,433 | -2.2% | 0.00% | -75.0% |
| Q4 2015 | $6,202,000 | +20.0% | 69,950 | +0.2% | 0.00% | +33.3% |
| Q3 2015 | $5,167,000 | -2.0% | 69,809 | +7.0% | 0.00% | 0.0% |
| Q2 2015 | $5,275,000 | +162.3% | 65,240 | +35.9% | 0.00% | +200.0% |
| Q1 2015 | $2,011,000 | +332.5% | 48,012 | +59.8% | 0.00% | – |
| Q4 2014 | $465,000 | +23.0% | 30,051 | +0.5% | 0.00% | – |
| Q3 2014 | $378,000 | +118.5% | 29,895 | +147.0% | 0.00% | – |
| Q2 2014 | $173,000 | -1.1% | 12,101 | -12.1% | 0.00% | – |
| Q1 2014 | $175,000 | – | 13,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |